Rohitashwa Prasad, Partner, JSA outlines the business strategies that pharma companies need to adopt for risk mitigation to deal with the impact of COVID – 19
The healthcare industry is a silver lining in the dark clouds looming over the Indian economy since the outbreak of the COVID-19 pandemic. Demand for certain kinds of drugs, devices and healthcare facilities is expected to grow significantly in the near future.
Please click here to read the full article.